NCT05627661Completed
Wearable Devices to Monitor Seizures in Autoimmune Epilepsy
Managing Multiple Seizure Types With Wearable Devices
Source: ClinicalTrials.gov · Last updated 26 Nov 2024
Brief summary (registry, in English)
The purpose of this research is to search for reproducible changes in a wide range of physical signals, including heart rate, muscle tone and activity and EEG before and at the onset of seizures in patients with epilepsy.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 33 (actual)
- First submitted
- 16 Nov 2022
- Start date
- 27 Oct 2022
- Primary completion date
- 22 Nov 2023
- Lead sponsor
- Mayo Clinic
- Diseases
- Epilepsy
- NCT number
- NCT05627661
What you commit to
- Study type: Interventional
- Participants enrolled: 33
- From 27 Oct 2022 to the primary completion date, 22 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Cognitive or psychiatric condition rendering patient unable to cooperate with data collection or manage and recharge smart watch and tablet computer devices. Presence of open or healing wounds near monitoring sites (infection risk).
Who the study is looking for
- Patients diagnosed with or suspected of having autoimmune epilepsy.
- Normal controls - cognitively normal subjects without epilepsy
Age in the registry: 18 years to 70 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic Minnesota Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.